Literature DB >> 29866855

Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features.

Sharathchandra Arandkar1, Noa Furth1, Yair Elisha1, Nishanth Belugali Nataraj2, Heiko van der Kuip3, Yosef Yarden2, Walter Aulitzky3, Igor Ulitsky2, Benjamin Geiger1, Moshe Oren4.   

Abstract

Within the tumor microenvironment, cancer cells coexist with noncancerous adjacent cells that constitute the tumor microenvironment and impact tumor growth through diverse mechanisms. In particular, cancer-associated fibroblasts (CAFs) promote tumor progression in multiple ways. Earlier studies have revealed that in normal fibroblasts (NFs), p53 plays a cell nonautonomous tumor-suppressive role to restrict tumor growth. We now wished to investigate the role of p53 in CAFs. Remarkably, we found that the transcriptional program supported by p53 is altered substantially in CAFs relative to NFs. In agreement, the p53-dependent secretome is also altered in CAFs. This transcriptional rewiring renders p53 a significant contributor to the distinct intrinsic features of CAFs, as well as promotes tumor cell migration and invasion in culture. Concordantly, the ability of CAFs to promote tumor growth in mice is greatly compromised by depletion of their endogenous p53. Furthermore, cocultivation of NFs with cancer cells renders their p53-dependent transcriptome partially more similar to that of CAFs. Our findings raise the intriguing possibility that tumor progression may entail a nonmutational conversion ("education") of stromal p53, from tumor suppressive to tumor supportive.

Entities:  

Keywords:  fibroblasts; lung cancer; matrix metalloproteinases; p53; tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 29866855      PMCID: PMC6016816          DOI: 10.1073/pnas.1719076115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

Review 1.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

2.  Distinct epigenetic changes in the stromal cells of breast cancers.

Authors:  Min Hu; Jun Yao; Li Cai; Kurt E Bachman; Frédéric van den Brûle; Victor Velculescu; Kornelia Polyak
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

Review 3.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

Review 4.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors:  Roopali Roy; Jiang Yang; Marsha A Moses
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

5.  Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou; George Trimis; Matrisa Frangou-Plemmenou; Agatha Pafiti-Kondi; Anastasios Kalofoutis
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

7.  Interaction of p53 with the CCT complex promotes protein folding and wild-type p53 activity.

Authors:  Antonio Garcia Trinidad; Patricia A J Muller; Jorge Cuellar; Marta Klejnot; Max Nobis; José María Valpuesta; Karen H Vousden
Journal:  Mol Cell       Date:  2013-06-06       Impact factor: 17.970

8.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

9.  Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.

Authors:  Maria-Giuseppina Procopio; Csaba Laszlo; Dania Al Labban; Dong Eun Kim; Pino Bordignon; Seung-Hee Jo; Sandro Goruppi; Elena Menietti; Paola Ostano; Ugo Ala; Paolo Provero; Wolfram Hoetzenecker; Victor Neel; Witold W Kilarski; Melody A Swartz; Cathrin Brisken; Karine Lefort; G Paolo Dotto
Journal:  Nat Cell Biol       Date:  2015-08-24       Impact factor: 28.824

Review 10.  Fibroblast heterogeneity in the cancer wound.

Authors:  Daniel Öhlund; Ela Elyada; David Tuveson
Journal:  J Exp Med       Date:  2014-07-28       Impact factor: 14.307

View more
  30 in total

Review 1.  The matrix in cancer.

Authors:  Thomas R Cox
Journal:  Nat Rev Cancer       Date:  2021-02-15       Impact factor: 60.716

2.  Modulation of p53 expression in cancer-associated fibroblasts prevents peritoneal metastasis of gastric cancer.

Authors:  Toshihiro Ogawa; Satoru Kikuchi; Motoyasu Tabuchi; Ema Mitsui; Yuta Une; Hiroshi Tazawa; Shinji Kuroda; Kazuhiro Noma; Toshiaki Ohara; Shunsuke Kagawa; Yasuo Urata; Toshiyoshi Fujiwara
Journal:  Mol Ther Oncolytics       Date:  2022-04-25       Impact factor: 6.311

3.  Stromal p53 Regulates Breast Cancer Development, the Immune Landscape, and Survival in an Oncogene-Specific Manner.

Authors:  Jinghai Wu; Xin Liu; Julie A Wallace Reeser; Anthony J Trimboli; Thierry Pécot; Gina M Sizemore; Shan K Naidu; Soledad A Fernandez; Lianbo Yu; Michael Hallett; Morag Park; Gustavo W Leone; Blake E Hildreth; Michael C Ostrowski
Journal:  Mol Cancer Res       Date:  2022-08-05       Impact factor: 6.333

4.  Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features.

Authors:  Gal Benor; Garold Fuks; Suet-Feung Chin; Oscar M Rueda; Saptaparna Mukherjee; Sharathchandra Arandkar; Yael Aylon; Carlos Caldas; Eytan Domany; Moshe Oren
Journal:  Mol Oncol       Date:  2020-06-23       Impact factor: 6.603

5.  TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment.

Authors:  Martino Maddalena; Giuseppe Mallel; Nishanth Belugali Nataraj; Michal Shreberk-Shaked; Ori Hassin; Saptaparna Mukherjee; Sharathchandra Arandkar; Ron Rotkopf; Abby Kapsack; Giuseppina Lambiase; Bianca Pellegrino; Eyal Ben-Isaac; Ofra Golani; Yoseph Addadi; Emma Hajaj; Raya Eilam; Ravid Straussman; Yosef Yarden; Michal Lotem; Moshe Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

6.  Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels.

Authors:  David Novo; Nikki Heath; Louise Mitchell; Giuseppina Caligiuri; Amanda MacFarlane; Dide Reijmer; Laura Charlton; John Knight; Monika Calka; Ewan McGhee; Emmanuel Dornier; David Sumpton; Susan Mason; Arnaud Echard; Kerstin Klinkert; Judith Secklehner; Flore Kruiswijk; Karen Vousden; Iain R Macpherson; Karen Blyth; Peter Bailey; Huabing Yin; Leo M Carlin; Jennifer Morton; Sara Zanivan; Jim C Norman
Journal:  Nat Commun       Date:  2018-11-29       Impact factor: 14.919

7.  p53: not just a tumor suppressor.

Authors:  Moshe Oren
Journal:  J Mol Cell Biol       Date:  2019-07-19       Impact factor: 6.216

8.  Deregulated lncRNA expression profile in the mouse lung adenocarcinomas with KRAS-G12D mutation and P53 knockout.

Authors:  Meiqin Zhang; Nan Jiang; Renjie Cui; Sichen Du; Huayuan Ou; Tinglan Chen; Runsheng Ge; Duan Ma; Jin Zhang
Journal:  J Cell Mol Med       Date:  2019-08-14       Impact factor: 5.310

9.  A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.

Authors:  Michal Shreberk-Shaked; Bareket Dassa; Sanju Sinha; Silvia Di Agostino; Ido Azuri; Saptaparna Mukherjee; Yael Aylon; Giovanni Blandino; Eytan Ruppin; Moshe Oren
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

Review 10.  Diversity and Biology of Cancer-Associated Fibroblasts.

Authors:  Giulia Biffi; David A Tuveson
Journal:  Physiol Rev       Date:  2020-05-28       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.